Category Archive: FierceMarkets

Elliott Management drops bid for Athenahealth, tanking the health tech company’s stock

Athenahealth’s share price plummeted Tuesday morning after reports indicated that Elliott Management was backing away from its bid for the company. Elliott’s Paul Singer was considering a $160-a-share bid.

Senate passes massive opioid package, bill to ban gag clauses

The opioid package will now head to reconciliation with the House of Representatives before advancing for the president’s signature. The Senate also passed a measure aimed at addressing high drug prices by banning contract clauses that stop pharmacists…

Study says Medicaid expansion in Michigan improved beneficiaries’ financial health

Newly eligible beneficiaries saw their bills in collection, especially medical bills, decrease by hundreds of dollars between 2014 and 2015.

Health IT Roundup—Minnesota hospital filmed patients without consent; Are providers ready for the death of faxes?

CMS wants to kill the fax machines, but providers and IT staff might not be ready; Fairview Southdale Hospital in Minnesota was found filming patients without their knowledge or consent; plus more health IT news of note.

Counties with greatest well-being for seniors cost Medicare thousands less, study finds

Medicare spends nearly $1,000 less per beneficiary in counties where residents are not only healthy, but happy and satisfied with their lives.

More than half of consumers don’t understand basic aspects of the healthcare system, survey finds

Ensuring that consumers understand their insurance could save billions in administrative costs, according to an Accenture analysis. The best way to do this? Simplify the system.

MACPAC continues to ponder value of collaborations between states

At its monthly meeting on Thursday, the Medicaid and CHIP Payment and Access Commission continued its discussion of whether federal policies can—or should—help states collaborate to bolster their administrative capacity. This time, two key officials ch…

CVS’ Larry Merlo defends rebates, touts pending Aetna deal at Morgan Stanley conference

With the Trump administration’s focus on curbing high prescription costs, drug rebates negotiated by pharmacy benefit managers have become a popular whipping boy. But CVS CEO Larry Merlo said he doesn’t foresee either going away anytime soon.

Russian Twitter trolls attempted to cull opposition to the ACA during repeal attempts

Twitter and the government must do more to stop the spread of messages that can deceitfully sway public sentiment, experts say.

States are trying to lower drug prices. Here’s how their efforts are being thwarted

Those states are finding their efforts hit by heavy opposition, according to a perspective piece published in The New England Journal of Medicine on Wednesday.

Older posts «

Explore the Archive